# IGC Pharma, Inc.: Form 8-K, filed May 25, 2017

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: 8-K
- Filed: 2017-05-25
- Accepted by EDGAR: May 25, 2017, 16:09 ET
- Period: 2017-05-25
- Accession: 0001185185-17-001264
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518517001264/indiaglobal8k052517.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518517001264/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518517001264/indiaglobal8k052517.htm

Filed May 25, 2017.
Source: SEC EDGAR, the filing index for accession 0001185185-17-001264. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.
